Colinz Laboratories Ltd.
BSE: 531210
₹80.10
₹1.67
(2.13%)
As on 04-Aug-2026 10:40IST
Market cap
₹20 Cr
Revenue (TTM)
₹6 Cr
P/E Ratio
7.1
P/B Ratio
1.6
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹3 Cr
-
ROE
5.4 %
-
ROCE
6.7 %
-
Industry P/E
41.97
-
EV/EBITDA
13.4
-
Debt to Equity
0.1
-
Book Value
₹49.4
-
EPS
₹2
-
Face value
10
-
Shares outstanding
2,519,100
10 Years Aggregate
CFO
₹4.28 Cr
EBITDA
₹4.44 Cr
Net Profit
₹2.71 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Colinz Lab
| 49.4 | 3.3 | 73.8 | 84.0 | 29.7 | 27.4 | 23.7 |
|
BSE Healthcare
| 17.2 | 1.6 | 14.1 | 15.0 | 22.5 | 13.9 | 12.2 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Colinz Lab
| -25.0 | 74.4 | -7.0 | 55.5 | 96.1 | 42.7 | 7.9 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Colinz Lab
|
80.1 | 19.8 | 5.8 | 2.8 | 3.1 | 5.1 | 7.1 | 1.6 |
| 3,207.8 | 25,542.6 | 1,461.8 | 387.4 | 34.5 | 25.2 | 66.1 | 14.8 | |
| 835.6 | 20,796.4 | 5,632.3 | 662.4 | 17.2 | 14.3 | 31.4 | 4.2 | |
| 7.2 | 7.3 | 0.4 | -0.2 | -61.3 | -24.7 | -- | 10.3 | |
| 1,645.0 | 4,015.3 | 370.6 | 97.8 | 27.0 | 12.3 | 41.1 | 4.7 | |
| 1,542.2 | 17,886.1 | 1,543.3 | -48.6 | 3.6 | -0.6 | -- | 3.1 | |
| 49.2 | 186.4 | 134.8 | -13.6 | -7.5 | -- | -- | -4.2 | |
| 200.9 | 26,493.8 | 9,205.3 | -371.8 | 1.7 | -3.8 | -- | 3.3 | |
| 362.1 | 3,404.3 | 897.8 | 89.5 | 14.8 | 13.5 | 33.2 | 4.2 | |
| 411.3 | 16,205.3 | 3,600.2 | 221.0 | 9.7 | 5.6 | 73.3 | 3.4 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Colinz Lab
Colinz Laboratories Limited manufactures and markets pharmaceutical formulations in India It provides pharmaceutical formulations in the dosage forms of tablets, capsules, granules, liquid orals, injectables, ointments, creams, etc.; and specialized... products for gynecology, cardiology, gastroenterology, etc. The company's allopathy products include oncology products and antiritrovirals; and products for other therapeutic areas, such as antibiotics, anti-pyretics, anti-fungals, anti-malarials, anti-virals, anti-manics, anti-convulsants, anti-migraines, anti-allergics, anti-diarrhoeals, anti-inflammatory, anti-piles, anthelmintics, anti-emetics, anti-spasmodics, infestations, sedatives, cerebral activators, ulcer healing agents, laxatives, probiotics, digestive enzymes, topical steroids, ear/eye drops, hormone, sunscreens and vitamins, etc., as well as drugs used in protozoal infestations and neuropathy. It also provides ayurvedic products, including anti-diarrhoeals, anti-pyretics, anti-inflammatories, anti-spasmodics, cough syrups, apetite stimulating agents, memory boosters, anti-piles, antacids, liver tonics, ulcer healing agents, digestive agents, ear drops, uterine tonics, anti-diabetics, and general tonics, as well as drugs to treat oligospermia and erectile dysfunction. In addition, the company offers nutraceuticals that include spirulina tabs/caps; spirulina with vitamins and minerals; omega 3 fatty acids caps in softgel; codliver oil with vitamin caps in soft gel; collagen, glucosamine, and chondroitin tabs; amino acids tabs/caps; L-arginine with proantocyanidin granules; and hair growth formulas, etc. The company was founded in 1986 and is based in Mumbai, India. Read more
-
Incorporated
1986
-
Chairman
--
-
Managing Director
--
-
Headquarters
Mumbai, Maharashtra
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsNo News & Announcements are available.
FAQs for Colinz Lab
What is the current share price of Colinz Laboratories Ltd Today?
The share price of Colinz Laboratories Ltd is ₹80.10 (BSE) as of 04-Aug-2026 10:40 IST. Colinz Laboratories Ltd has given a return of 29.7% in the last 3 years.
What is the current PB & PE ratio of Colinz Laboratories Ltd?
The P/E ratio of Colinz Laboratories Ltd is 7.07 times as on 03-Aug-2026, a 83 discount to its peers’ median range of 41.97 times.
The P/B ratio of Colinz Laboratories Ltd is 1.59 times as on 03-Aug-2026, a 62 discount to its peers’ median range of 4.22 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
36.75
|
1.93
|
|
2024
|
19.44
|
1.06
|
|
2023
|
19.28
|
1.08
|
|
2022
|
24.60
|
1.09
|
|
2021
|
12.98
|
0.37
|
What is the 52 Week High and Low of Colinz Laboratories Ltd?
The 52-week high and low of Colinz Laboratories Ltd are Rs 87.91 and Rs 36.11 as of 04-Aug-2026.
What is the market cap of Colinz Laboratories Ltd?
Colinz Laboratories Ltd has a market capitalisation of ₹ 20 Cr as on 03-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Colinz Laboratories Ltd?
Before investing in Colinz Laboratories Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.